MRI study during cornea cross-linking for keratoconus
Part of Brain & nervous system, Eyes & vision, Injuries & trauma, Pain clinical trials.
This trial uses an MRI scan (and a close-up eye scan) to study what happens in the cornea during treatment for keratoconus. It may help doctors better understand how treatment works and who benefits most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 8 and 35 years old
- For the “treatment” group: you have a diagnosis of keratoconus and want cross-linking (CXL)
- For the “control” group: you do not have keratoconus
- You can safely have an MRI: no metal implants (and no metal tattoos above the chest) and you can lie still for about 60 minutes
- You are able to understand the consent in English with parent/guardian help
- You must not be pregnant and must not have had an allergy to numbing eye drops before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether treating donor corneal tissue with a special light and vitamin drops (called cross-linking) before a transplant helps improve outcomes for people with keratoconus. If you need a corneal transplant, this could strengthen the donor tissue and potentially reduce the need for future procedures.
This study tests whether a special “Brillouin” microscope scan can spot corneal ectasia and related cornea conditions. It may help doctors diagnose problems earlier and better sort out who needs closer eye care.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
Hear when a new Surgical Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.